STEMI (ST ELEVATION MI)
Clinical trials for STEMI (ST ELEVATION MI) explained in plain language.
Never miss a new study
Get alerted when new STEMI (ST ELEVATION MI) trials appear
Sign up with your email to follow new studies for STEMI (ST ELEVATION MI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could dropping aspirin be safer for heart attack patients?
Disease control Recruiting nowThis study is testing if taking just one blood-thinning drug (ticagrelor) is better than the standard two-drug combo (ticagrelor plus aspirin) for people who have had a heart attack and are being treated with medication alone. It aims to see if the single drug reduces the risk of…
Matched conditions: STEMI (ST ELEVATION MI)
Phase: PHASE3 • Sponsor: Montreal Heart Institute • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New hope for heart attack recovery: drug aims to shield Micro-Vessels
Disease control Recruiting nowThis study is testing if a drug called ranolazine can help protect the smallest blood vessels in the heart after a major heart attack. It involves 100 patients who have had a severe heart attack and still have other significant blockages. Researchers will compare patients taking …
Matched conditions: STEMI (ST ELEVATION MI)
Phase: PHASE2, PHASE3 • Sponsor: Federico II University • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New 'Balloon-Only' heart attack treatment could free young patients from lifelong stent risks
Disease control Recruiting nowThis study is testing a new approach for treating heart attacks in adults under 50. It compares a drug-coated balloon, which leaves nothing behind in the artery, to the standard drug-eluting stent, which is a permanent implant. The goal is to see if the balloon method works as we…
Matched conditions: STEMI (ST ELEVATION MI)
Phase: PHASE3 • Sponsor: National Institute of Cardiovascular Diseases, Pakistan • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC